MedTrace Logo

A Study of CAR-T Cells in Subjects With Systemic Lupus Erythematosus

NCT06900764 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-07-17

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with SLE.

Conditions

  • Systemic Lupus Erythematosus (SLE)

Interventions

DRUG

CAR-T cell

CAR-T cell

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-10
Primary Completion
2027-11-15
Completion
2027-12-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06900764 on ClinicalTrials.gov